Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects-Reference-Cited by-同舟云学术

Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects

Published:1983-10 Issue:4 Volume:75 Page:32-39
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Mehta Jawahar,Feldman Robert L.,Marx J.Danie,Kelly Georgia Anne

Publisher

Elsevier BV

Subject

General Medicine

Reference17 articles.

1. Clinical investigation of an antagonist of alpha and beta adrenoreceptors-AH 5158 A;Collier;Br J Pharmacol,1972

2. Pharmacology of AH 5158: A drug which blocks both alpha and beta adreno-receptors;Farmer;Br J Pharmacol,1972

3. Hemodynamic effects of labetalol, an alpha- and beta-adrenergic blocking agent, in hypertensive subjects;Mehta;Circulation,1977

4. Labetalol therapy in patients with systemic hypertension and angina pectoris. Effects of combined alpha and beta adreno-receptor blockade;Frishman;Am J Cardiol,1981

5. Hemodynamic effects of combined alpha and beta adreno-receptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise;Koch;Br J Clin Pharmacol,1976

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypertensive Emergencies;Emergency Medicine Clinics of North America;1995-11

2. Clinical Pharmacokinetics and Kinetic-Dynamic Relationships of Dilevalol and Labetalol;Clinical Pharmacokinetics;1991-08

3. Selection of antihypertensive therapy;American Heart Journal;1990-06

4. Drugs Acting on Multiple Receptors: β-Blockers with Additional Properties;Pharmacology of Antihypertensive Therapeutics;1990

5. Labetalol;Drugs;1989-05